• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床预测因素与 COVID-19 严重程度和死亡率:一个视角。

Clinical Predictors of COVID-19 Severity and Mortality: A Perspective.

机构信息

Department of Biochemistry, All India Institute of Medical Sciences, Bathinda, India.

Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.

出版信息

Front Cell Infect Microbiol. 2021 Oct 25;11:674277. doi: 10.3389/fcimb.2021.674277. eCollection 2021.

DOI:10.3389/fcimb.2021.674277
PMID:34760713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8573222/
Abstract

The COVID-19 pandemic has caused huge socio-economic losses and continues to threat humans worldwide. With more than 4.5 million deaths and more than 221 million confirmed COVID-19 cases, the impact on physical, mental, social and economic resources is immeasurable. During any novel disease outbreak, one of the primary requirements for effective mitigation is the knowledge of clinical manifestations of the disease. However, in absence of any unique identifying characteristics, diagnosis/prognosis becomes difficult. It intensifies misperception and leads to delay in containment of disease spread. Numerous clinical research studies, systematic reviews and meta-analyses have generated considerable data on the same. However, identification of some of the distinct clinical signs and symptoms, disease progression biomarkers and the risk factors leading to adverse COVID-19 outcomes warrant in-depth understanding. In view of this, we assessed 20 systematic reviews and meta-analyses with an intent to understand some of the potential independent predictors/biomarkers/risk factors of COVID-19 severity and mortality.

摘要

COVID-19 大流行造成了巨大的社会经济损失,并继续威胁着全世界的人类。全球已有超过 450 万人死亡,超过 2.21 亿例确诊的 COVID-19 病例,对身体、心理、社会和经济资源的影响是不可估量的。在任何新疾病爆发期间,有效缓解的首要要求之一是了解疾病的临床表现。然而,由于缺乏任何独特的识别特征,诊断/预后变得困难。这加剧了误解,并导致疾病传播的控制延迟。大量的临床研究、系统评价和荟萃分析已经产生了大量关于这方面的数据。然而,确定一些独特的临床体征和症状、疾病进展生物标志物以及导致 COVID-19 不良结局的危险因素需要深入了解。有鉴于此,我们评估了 20 项系统评价和荟萃分析,旨在了解 COVID-19 严重程度和死亡率的一些潜在独立预测因素/生物标志物/危险因素。

相似文献

1
Clinical Predictors of COVID-19 Severity and Mortality: A Perspective.临床预测因素与 COVID-19 严重程度和死亡率:一个视角。
Front Cell Infect Microbiol. 2021 Oct 25;11:674277. doi: 10.3389/fcimb.2021.674277. eCollection 2021.
2
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
3
The impact of the COVID-19 pandemic on children and young people.新冠疫情对儿童和青少年的影响。
Psychiatriki. 2023 Dec 29;34(4):265-268. doi: 10.22365/jpsych.2023.024. Epub 2023 Nov 14.
4
Early prediction of level-of-care requirements in patients with COVID-19.对 COVID-19 患者的医疗照护需求进行早期预测。
Elife. 2020 Oct 12;9:e60519. doi: 10.7554/eLife.60519.
5
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.旅行相关的控制措施以遏制 COVID-19 大流行:快速综述。
Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717.
6
COVID-19 pandemic: A multidisciplinary perspective on the pathogenesis of a novel coronavirus from infection, immunity and pathological responses.COVID-19 大流行:从感染、免疫和病理反应角度看新型冠状病毒的发病机制——多学科视角。
Front Immunol. 2022 Aug 26;13:978619. doi: 10.3389/fimmu.2022.978619. eCollection 2022.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为遏制新冠疫情而采取的措施:一项范围综述
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD013812. doi: 10.1002/14651858.CD013812.
9
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
10
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.

引用本文的文献

1
Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes.组织因子途径抑制物升高会延迟新型冠状病毒肺炎患者的凝血酶生成,但与临床结局无关。
Blood Vessel Thromb Hemost. 2025 Apr 29;2(3):100071. doi: 10.1016/j.bvth.2025.100071. eCollection 2025 Aug.
2
Identifying Key Hematological and Biochemical Indicators of Disease Severity in COVID-19 and Non-COVID-19 Patients.识别新冠病毒感染患者和非新冠病毒感染患者疾病严重程度的关键血液学和生化指标
Diagnostics (Basel). 2025 May 29;15(11):1374. doi: 10.3390/diagnostics15111374.
3
Evaluation of methylation changes in blood cells of COVID-19 patients as a biomarker of severity of the infection.评估新冠病毒感染患者血细胞中的甲基化变化作为感染严重程度的生物标志物。
BMC Infect Dis. 2025 May 31;25(1):778. doi: 10.1186/s12879-025-11181-1.
4
Predicting coronavirus disease 2019 severity using explainable artificial intelligence techniques.使用可解释人工智能技术预测2019冠状病毒病的严重程度。
Sci Rep. 2025 Mar 19;15(1):9459. doi: 10.1038/s41598-025-85733-5.
5
Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile.智利一个社区医疗网络中,SARS-CoV-2感染的人口统计学、临床特征与严重并发症之间的关联。
PLoS One. 2024 Dec 30;19(12):e0314376. doi: 10.1371/journal.pone.0314376. eCollection 2024.
6
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-interstitial lung disease, and idiopathic pulmonary fibrosis.新型冠状病毒肺炎、新型冠状病毒肺炎后间质性肺疾病和特发性肺纤维化中的趋同和发散性免疫异常
Am J Physiol Cell Physiol. 2025 Jan 1;328(1):C199-C211. doi: 10.1152/ajpcell.00528.2024. Epub 2024 Nov 7.
7
Model for End-Stage Liver Disease Including Na, Age, and Sex Is Powerful Predictor of Survival in COVID-19 Patients on Extracorporeal Membrane Oxygenation.包含钠、年龄和性别的终末期肝病模型是接受体外膜肺氧合治疗的COVID-19患者生存的有力预测指标。
Diagnostics (Basel). 2024 Sep 4;14(17):1954. doi: 10.3390/diagnostics14171954.
8
Interplay of Demographic Influences, Clinical Manifestations, and Longitudinal Profile of Laboratory Parameters in the Progression of SARS-CoV-2 Infection: Insights from the Saudi Population.新冠病毒感染进展中人口统计学影响、临床表现及实验室参数纵向概况的相互作用:来自沙特人群的见解
Microorganisms. 2024 May 18;12(5):1022. doi: 10.3390/microorganisms12051022.
9
Factors Associated with All-Cause 30-Day Mortality in Indonesian Inpatient COVID-19 Patients at Cipto Mangunkusumo National General Hospital.雅加达中央医院(Cipto Mangunkusumo National General Hospital)印度尼西亚住院COVID-19患者全因30天死亡率的相关因素
J Clin Med. 2024 May 20;13(10):2998. doi: 10.3390/jcm13102998.
10
Role of epinephrine in attenuating cytokine storm, decreasing ferritin, and inhibiting ferroptosis in SARS-CoV-2.肾上腺素在减轻细胞因子风暴、降低铁蛋白以及抑制新型冠状病毒中的铁死亡方面的作用。
Egypt Heart J. 2024 Feb 20;76(1):22. doi: 10.1186/s43044-024-00455-9.

本文引用的文献

1
Origins of SARS-CoV-2: Focusing on Science.严重急性呼吸综合征冠状病毒2的起源:聚焦科学
Infect Dis Immun. 2021 Apr 20;1(1):3-4. doi: 10.1097/ID9.0000000000000008. eCollection 2021 Apr.
2
Obesity and Mortality Among Patients Diagnosed With COVID-19: A Systematic Review and Meta-Analysis.新冠病毒疾病确诊患者的肥胖与死亡率:一项系统综述和荟萃分析
Front Med (Lausanne). 2021 Feb 5;8:620044. doi: 10.3389/fmed.2021.620044. eCollection 2021.
3
COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.高检测环境下拉丁美洲年龄和性别与 COVID-19 病死率的关系:智利,2020 年 3 月至 8 月。
Infect Dis Poverty. 2021 Feb 3;10(1):11. doi: 10.1186/s40249-020-00785-1.
4
Clinical Characteristics and Diagnostic Challenges of COVID-19: An Update From the Global Perspective.从全球视角看 COVID-19 的临床特征和诊断挑战:最新进展。
Front Public Health. 2021 Jan 11;8:567395. doi: 10.3389/fpubh.2020.567395. eCollection 2020.
5
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.新型冠状病毒肺炎患者肝损伤的发生率及其与临床结局的相关性:系统评价与荟萃分析。
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13072-13088. doi: 10.26355/eurrev_202012_24215.
6
Objective Sensory Testing Methods Reveal a Higher Prevalence of Olfactory Loss in COVID-19-Positive Patients Compared to Subjective Methods: A Systematic Review and Meta-Analysis.目的:与主观方法相比,客观感觉测试方法显示 COVID-19 阳性患者的嗅觉丧失发生率更高:系统评价和荟萃分析。
Chem Senses. 2020 Dec 5;45(9):865-874. doi: 10.1093/chemse/bjaa064.
7
Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.新型冠状病毒肺炎患者严重程度和死亡的预后因素:系统评价。
PLoS One. 2020 Nov 17;15(11):e0241955. doi: 10.1371/journal.pone.0241955. eCollection 2020.
8
Predictors of COVID-19 severity: a systematic review and meta-analysis.预测 COVID-19 严重程度的因素:系统评价和荟萃分析。
F1000Res. 2020 Sep 9;9:1107. doi: 10.12688/f1000research.26186.2. eCollection 2020.
9
Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions.预测 COVID-19 院内死亡率的因素:一项全面的系统综述和荟萃分析,探讨了年龄、性别和健康状况的差异。
PLoS One. 2020 Nov 3;15(11):e0241742. doi: 10.1371/journal.pone.0241742. eCollection 2020.
10
Disparities in case frequency and mortality of coronavirus disease 2019 (COVID-19) among various states in the United States.美国各州 2019 冠状病毒病(COVID-19)病例频率和死亡率的差异。
Ann Med. 2021 Dec;53(1):151-159. doi: 10.1080/07853890.2020.1840620.